KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer. [electronic resource]
Producer: 20200203Description: 559-572.e7 p. digitalISSN:- 1878-3686
- Adenomatous Polyposis Coli Protein -- genetics
- Adult
- Aged
- Animals
- Antineoplastic Agents, Immunological -- pharmacology
- Cell Line, Tumor
- Cell Movement
- Chemokines, CXC -- metabolism
- Colorectal Neoplasms -- drug therapy
- Drug Resistance, Neoplasm -- genetics
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Interferon Regulatory Factor-2 -- genetics
- Male
- Mice, Inbred C57BL
- Mice, Inbred NOD
- Mice, SCID
- Mice, Transgenic
- Middle Aged
- Myeloid-Derived Suppressor Cells -- drug effects
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Proto-Oncogene Proteins p21(ras) -- genetics
- Receptors, Interleukin-8B -- metabolism
- Signal Transduction
- Tumor Escape
- Tumor Microenvironment
- Tumor Suppressor Protein p53 -- genetics
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.